Journals / Epilepsi / 2019 / Cilt: 25 - Sayı: 2

The Effect of Antiepileptic Drug Therapy on Cognition in Drug-Responsive Mesial Temporal Lobe Epilepsy

İlaç Tedavisine İyi Yanıt Veren Mezial Temporal Lob Epilepsili Hastalarda Tedavinin Bellek ve Yürütücü İşlevler Üzerine Etkisi

Journal
Epilepsi
Pages
88–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results indicate that antiepileptic drugs may have a negative impact on cognition.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to examine the effect of antiepileptic drugs on memory and executive functions in drug-responsive mesial temporal lobe epilepsy with unilateral hippocampal sclerosis (MTLE-HS).
📊
Key Findings & Data:Methods: The patients were classified according to the 2017 International League Against Epilepsy classification of seizures.
💡
Conclusion & Impact:These results indicate that antiepileptic drugs may have a negative impact on cognition.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to examine the effect of antiepileptic drugs on memory and executive functions in drug-responsive mesial temporal lobe epilepsy with unilateral hippocampal sclerosis (MTLE-HS). Methods: The patients were classified according to the 2017 International League Against Epilepsy classification of seizures. Thirty-four patients with the diagnosis of MTLE-HS and 30 matched controls were enrolled. Patients treated with a maximum 2 anti-epileptic drugs and experiencing no more than 2 instances of focal impaired awareness per month or 2 focal to bilateral tonic-clonic seizures in a year were accepted as drug-responsive. Patients receiving monotherapy (PRM) and polytherapy (PRP) were compared in terms of memory and executive functions. Results: There were 19 (55.8%) monotherapy patients in the group and 15 (44.2%) polytherapy patients. The maximum number of learned words recorded in a verbal memory test, the immediate and delayed recall score, and the logical memory score were all statistically significantly lower in the PRP group compared with the PRM group (p<0.05). The results of the verbal attention test and verbal fluency test were also significantly lower in the PRP group (p<0.01). Conclusion: Significantly greater impairment was observed in several aspects of cognitive function in the PRP group. These results indicate that antiepileptic drugs may have a negative impact on cognition.

Özet

Amaç: Çalışmamızda ilaç tedavisine iyi yanıt veren, tek taraflı hipokampal sklerozu olan mezial temporal lob epilepsili (MTLE) hastaların, bellek ve frontal lob fonksiyonlarını inceleyerek antiepileptik ilaçların (AEİ) kognisyon üzerine, sık tekrarlayan nöbetlerden bağımsız olarak etkisi olup olmadığını araştırmayı amaçladık. Gereç ve Yöntem: Hastalar 2017 ILAE Revize Nöbet Sınıflamasına göre sınıflandırıldı. MTLE tanısı almış olan, ilaca yanıtlı grup olarak en fazla iki AEİ alan ve ayda ikiden az fokal farkındalığın bozulduğu nöbet veya yılda ikiden az fokalden iki taraflı tonik kloniğe dönüşen nöbet geçiren 34 hasta ve 30 benzer yaş, cinsiyet ve eğitim durumuna sahip sağlıklı kontrol çalışmamıza dahil edildi. Çalışmamızda monoterapi ve politerapi alan hastalar, bellek ve frontal lob fonksiyonları yönünden karşılaştırıldı. Bulgular: Otuz dört hastanın 19’u (%55.8) monoterapi, 15’i (%44.2) politerapi almaktaydı. Politerapi alan hastaların monoterapi alan hastalara göre, sözel belleğin özellikle toplam öğrenme parametresinin anlamlı düzeyde düşük olduğu, kısa ve uzun süreli görsel belleğin ve mantıksal belleğin ileri düzeyde etkilenmiş olduğu görüldü (p<0.05). Politerapi alan hastaların monoterapi alan hastalara göre dikkat testinde ve verbal akıcılık testinde ileri düzeyde anlamlı bozulma saptandı (p<0.01). Sonuç: Sonuç olarak kullanılan AEİ sayısı arttıkça değerlendirdiğimiz çoğu kognitif fonksiyonun performanslarında anlamlı düzeyde etkilenme görülmüştür. Bu bulgular, AEİ’lerin kognisyon üzerine olan olumsuz etkisini desteklemektedir.

🔖

Cite This Article

YÜKSEL, B., USLU, S. Ç., SARIAHMETOĞLU, H., KESKİNKILIÇ, C., ATAKLI, D. (2019). The Effect of Antiepileptic Drug Therapy on Cognition in Drug-Responsive Mesial Temporal Lobe Epilepsy. Epilepsi, Cilt: 25 - Sayı: 2, 88–93. https://ajindex.com/articles/194685

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Özkara Ç, Bora İ, Yeni SN, Gürses C. Temporal Lob Epilepsileri. 1st ed. İstanbul: Nobel Tıp Kitabevleri; 2008. p. 301–17.
  2. Sencer S, Kinay D, Gürses C, Kurt BB, Poyanli A, Gökyiğit A, et al. Clinical and magnetic resonance imaging findings in patients with surgically treated mesial temporal sclerosis. Tani Girisim Radyol 2003;9(2):171–5. [Article in Turkish]. Kneebone AC. Presurgical neuropsychological evaluation for localization of the epileptogenic zone. Epilepsi surgery. 2nd ed. Philadelphia: Lippincott Williams&Wilkins; 2001. p. 487-946.
  3. Riley JD, Moore S, Cramer SC, Lin JJ. Caudate atrophy and impaired frontostriatal connections are linked to execu tive dysfunction in temporal lobe epilepsy. Epilepsy Behav 2011;21(1):80–7. Trimble MR. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 1987;28 Suppl 3:S37–45. Shorvon SD, Reynolds EH. Reduction in polypharmacy for epilepsy. Br Med J 1979;2(6197):1023–5. Hamed SA. The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications. CNS Neurosci Ther 2009;15(2):134–56.
  4. Prpic I, Boban M, Vlasic-Cicvaric I, Korotaj Z. Effect of lamotrigine on cognition in children with epilepsy. Neurology 2007;68(10):797–8.
  5. Harden CL, Lazar LM, Pick LH, Nikolov B, Goldstein MA, Carson D, et al. A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999;40(8):1129–34.
  6. Park SP, Hwang YH, Lee HW, Suh CK, Kwon SH, Lee BI. Longterm cognitive and mood effects of zonisamide monotherapy in epilepsy patients. Epilepsy Behav 2008;12(1):102–8.
  7. Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res 2006;68(3):181–8.
  8. Thompson PJ, Baxendale SA, Duncan JS, Sander JW. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000;69(5):636–41.
  9. Ortinski P, Meador KJ. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 2004;5 Suppl 1:S60–5. Drane DL, Meador KJ. Epilepsy, anticonvulsant drugs and cognition. Baillieres Clin Neurol 1996;5(4):877–85.
  10. Mazzocco MM, Kover ST. A longitudinal assessment of executive function skills and their association with math performance. Child Neuropsychol 2007;13(1):18–45.
  11. Witt JA, Elger CE, Helmstaedter C. Impaired verbal fluency under topiramate-evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy. Eur J Neurol 2013;20(1):130–7.